Atlas Trials

6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

Clinical trial NCT07198685 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07198685
Sponsor
Wuhan Pulmonary Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Treat to TargetTreatment Duration
Start date
2025-09-30
Primary completion
2027-09-30
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.